Biocon Biologics to offer 15% stake to Serum Institute Life Sciences

Biocon Biologics, a subsidiary of Biocon, on Thursday said it will offer around 15 per cent stake to Serum Institute Life Sciences at a post-money valuation of about $4.9 billion

from Companies https://ift.tt/3zi3Nxo
via IFTTT